Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
financials
Providers
CHS' hospital divestiture streak likely isn't over
Amid commentary on fourth quarter earnings, CEO Kevin Hammons said the 65-hospital company still has some early-stage deals in the works.
Dave Muoio
Feb 19, 2026 2:03pm
Ascension narrows H1 operating loss to $139M
Feb 17, 2026 4:25pm
Humana CEO: Insurer is ready to adapt if 2027 MA rates stay flat
Feb 11, 2026 12:30pm
CVS CEO Joyner calls 2027 MA rate notice 'disappointing'
Feb 10, 2026 1:00pm
Cordani: New PBM model aligns with reforms, FTC settlement
Feb 5, 2026 12:30pm
Providence's operations inch into positive territory during Q3
Nov 13, 2025 5:00pm